September 25, 2024 – Stockholm, Sweden
The Impact/100 is an annual list of the world’s most promising start-ups. It exists to highlight the power of entrepreneurship to drive positive change, in other words: It’s 100 ideas with the potential to change 1 billion lives.
The list is produced by Norrsken in collaboration with the world’s top VCs and NGOs, including A16Z, Khosla Ventures, EQT Foundation, and many more.
ClexBio was selected from 1200+ nominated companies worldwide, in the health, technology, and sustainability sectors. On 24th September, our logo was featured on the Nasdaq Tower in Times Square, New York as part of the New York Climate Week. We are excited to grow our company and scale the positive impact we have on the world. We can’t wait to follow the journeys of the 99 inspiring companies we share this achievement with. You can find the full list here: https://www.norrsken.org/impact100#list
About Norrsken
Norrsken is an impact ecosystem, the company runs award-winning Norrsken House hubs around the world, and their five VC funds have raised >500mUSD to back exceptional entrepreneurs who combine profit with positive global impact.
About ClexBio
ClexBio is a pre-clinical stage regenerative medicine company with a breakthrough platform for scalable, high-throughput generation of therapeutic tissues. We represent the next generation of cell therapy, leveraging fully functional bioengineered tissues to elevate the restorative ability of cells and produce a new class of curative treatments for some of the world’s most challenging medical conditions.
For all the latest updates, visit clexbio.com or follow us on LinkedIn.
